PRINCIPAL DISPLAY PANEL - 50 mL Bag Label
NDC 0409-0528-13
50 mL
LEVOFLOXACIN
IN 5% DEXTROSE INJECTION 250 mg (5 mg/mL)
250 mg in 50 mL 5% Dextrose
USE IMMEDIATELY ONCE REMOVED FROM THE OVERWRAP
INFUSE OVER 60 MINUTES
FOR INTRAVENOUS INFUSION
No further dilution is necessary. Each 50 mL contains
a dilute solution equivalent of 250 mg of levofloxacin
(5 mg/mL) in 5% Dextrose. May contain Hydrochloric
Acid, NF and/or Sodium Hydroxide, NF to adjust pH to
3.8 – 5.8. Additives should not be added or infused
simultaneously through the same intravenous line.
Single-use container. Any unused portion should be
discarded. Usual Adult Dosage: See Insert. Sterile,
nonpyrogenic. Use only if solution is clear and
container is undamaged. Must not be used in series
connection. Avoid excessive heat.
RX ONLY
3
V
CONTAINS DEHP
PRINTED IN USA
IM-1639 (10/07)
Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
PRINCIPAL DISPLAY PANEL - 50 mL Bag Pouch
TO OPEN - TEAR AT NOTCH
ONE UNIT / NDC 0409-0528-13
50 mL
LEVOFLOXACIN
IN 5% DEXTROSE INJECTION 250 mg (5 mg/mL)
250 mg in 50 mL 5% Dextrose
ATTENTION PHARMACIST: DISPENSE THE ACCOMPANYING
MEDICATION GUIDE TO EACH PATIENT.
FOR INTRAVENOUS INFUSION
INFUSE OVER 60 MINUTES
LEAVE BAG IN OVERWRAP UNTIL USE.
Each 50 mL contains a dilute solution equivalent of 250 mg of levofloxacin (5 mg/mL) in
5% Dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF for pH
adjustment. pH range 3.8 – 5.8.
Usual Adult Dosage: See Insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.] Product may also be stored in a refrigerator, 2 to 8°C (36 to 46°F).
Avoid excessive heat. Protect from light. Protect from freezing.
Single-use container. Any unused portion should be discarded. Must not be used in
series connection. Additives should not be added or infused through the same
intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap
until ready to use. Use unit promptly when pouch is open. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired. Use only if solution is clear and the container is undamaged.
NO FURTHER DILUTION IS NECESSARY.
RX ONLY
F WR-1522
7
OTHER
Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
PRINCIPAL DISPLAY PANEL - 100 mL Bag Label
NDC 0409-0528-23
100 mL
LEVOFLOXACIN
IN 5% DEXTROSE INJECTION 500 mg (5 mg/mL)
500 mg in 100 mL 5% Dextrose
USE IMMEDIATELY ONCE REMOVED FROM THE OVERWRAP
INFUSE OVER 60 MINUTES
FOR INTRAVENOUS INFUSION
No further dilution is necessary. Each 100 mL
contains a dilute solution equivalent of 500 mg of
levofloxacin (5 mg/mL) in 5% Dextrose. May contain
Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to
adjust pH to 3.8 – 5.8. Additives should not be added
or infused simultaneously through the same
intravenous line. Single-use container. Any unused
portion should be discarded. Usual Adult Dosage: See
Insert. Sterile, nonpyrogenic. Use only if solution is
clear and container is undamaged. Must not be used
in series connection. Avoid excessive heat.
RX ONLY
3
V
CONTAINS DEHP
PRINTED IN USA
IM-1640 (10/07)
Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
PRINCIPAL DISPLAY PANEL - 100 mL Bag Pouch
TO OPEN - TEAR AT NOTCH
ONE UNIT / NDC 0409-0528-23
100 mL
LEVOFLOXACIN
IN 5% DEXTROSE INJECTION 500 mg (5 mg/mL)
500 mg in 100 mL 5% Dextrose
ATTENTION PHARMACIST: DISPENSE THE ACCOMPANYING
MEDICATION GUIDE TO EACH PATIENT.
FOR INTRAVENOUS INFUSION
INFUSE OVER 60 MINUTES
LEAVE BAG IN OVERWRAP UNTIL USE.
Each 100 mL contains a dilute solution equivalent of 500 mg of levofloxacin (5 mg/mL)
in 5% Dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF for
pH adjustment. pH range 3.8 – 5.8.
Usual Adult Dosage: See Insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.] Product may also be stored in a refrigerator, 2 to 8°C (36 to 46°F).
Avoid excessive heat. Protect from light. Protect from freezing.
Single-use container. Any unused portion should be discarded. Must not be used in
series connection. Additives should not be added or infused through the same
intravenous line. The overwrap is a moisture barrier. Do not remove unit from
overwrap until ready to use. Use unit promptly when pouch is open. After removing
the overwrap, check for minute leaks by squeezing container firmly. If leaks are found,
discard unit as sterility may be impaired. Use only if solution is clear and the container
is undamaged. NO FURTHER DILUTION IS NECESSARY.
RX ONLY
F WR-1523
7
other
Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
PRINCIPAL DISPLAY PANEL - 150 mL Bag Label
NDC 0409-0528-31
150 mL
LEVOFLOXACIN
IN 5% DEXTROSE INJECTION 750 mg (5 mg/mL)
750 mg in 150 mL 5% Dextrose
USE IMMEDIATELY ONCE REMOVED FROM THE OVERWRAP
INFUSE OVER 90 MINUTES
FOR INTRAVENOUS INFUSION
No further dilution is necessary. Each
150 mL contains a dilute solution equivalent
of 750 mg of levofloxacin (5 mg/mL) in 5%
Dextrose. May contain Hydrochloric Acid,
NF and/or Sodium Hydroxide, NF to adjust
pH to 3.8 – 5.8. Additives should not be
added or infused simultaneously through
the same intravenous line. Single-use
container. Any unused portion should be
discarded. Usual Adult Dosage: See Insert.
Sterile, nonpyrogenic. Use only if solution is
clear and container is undamaged. Must not
be used in series connection. Avoid
excessive heat.
RX ONLY
3
V
CONTAINS DEHP
PRINTED IN USA
IM-1641 (10/07)
Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
PRINCIPAL DISPLAY PANEL - 150 mL Bag Pouch
TO OPEN - TEAR AT NOTCH
ONE UNIT / NDC 0409-0528-31
150 mL
LEVOFLOXACIN
IN 5% DEXTROSE INJECTION 750 mg (5 mg/mL)
750 mg in 150 mL 5% Dextrose
ATTENTION PHARMACIST: DISPENSE THE ACCOMPANYING
MEDICATION GUIDE TO EACH PATIENT.
FOR INTRAVENOUS INFUSION
INFUSE OVER 90 MINUTES
LEAVE BAG IN OVERWRAP UNTIL USE.
Each 150 mL contains a dilute solution equivalent of
750 mg of levofloxacin (5 mg/mL) in 5% Dextrose.
May contain Hydrochloric Acid, NF and/or Sodium
Hydroxide, NF for pH adjustment. pH range 3.8 – 5.8.
Usual Adult Dosage: See Insert. Store at 20 to 25°C
(68 to 77°F). [See USP Controlled Room Temperature.]
Product may also be stored in a refrigerator, 2 to 8°C
(36 to 46°F). Avoid excessive heat. Protect from light.
Protect from freezing.
Single-use container. Any unused portion should be
discarded. Must not be used in series connection.
Additives should not be added or infused through
the same intravenous line. The overwrap is a moisture
barrier. Do not remove unit from overwrap until ready
to use. Use unit promptly when pouch is open. After
removing the overwrap, check for minute leaks by
squeezing container firmly. If leaks are found, discard
unit as sterility may be impaired. Use only if solution is
clear and the container is undamaged. NO FURTHER
DILUTION IS NECESSARY.
RX ONLY
F WR-1524
7
other
Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
